Although previous studies have identified the regulatory role of Lp-PLA2 in NAFLD (Colak et al., 2012), its specific role and underlying mechanisms in NASH remain largely unknown. This evidence concerns the gene PLA2G7 and metabolic dysfunction-associated steatotic liver disease.